CERS
Cerus Corporation
Medical Devices · Healthcare · United States
2.28
close · 2026-10-30
value
54
cheaper than peers54
quality
46
stronger fundamentals46
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 1 year ago | 1.9% | 74 |
| cash flow yield, latest year | 0.2% | 62 |
| price to sales | 2.07× | 60 |
| earnings yield, 1 year ago | -4.8% | 59 |
| earnings yield, latest year | -3.5% | 58 |
| earnings yield, 2 years ago | -9.2% | 51 |
| earnings yield, 3 years ago | -10.5% | 46 |
| cash flow yield, 3 years ago | -6.0% | 45 |
| cash flow yield, 2 years ago | -10.4% | 39 |
| price to book | 6.55× | 24 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -10.8% | 57 |
| revenue growth | 9.5% | 57 |
| operating margin | -3.2% | 52 |
| debt to equity | 108.6% | 27 |
4 of 4 measures available
Facts
| market cap | $459M |
| free cash flow | $875,250 |
| employees | 261 |
| first trade | 1997-01-31 |
| next earnings | 2026-11-02 |
| fundamentals updated | 2026-08-14 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.08 | -0.11 | -0.21 | -0.24 |
| free cash flow | $1.1M | $8.5M | -$47.8M | -$27.6M |
| net income | -$15.6M | -$20.9M | -$37.5M | -$42.8M |
| revenue | $206.1M | $180.3M | $156.4M | $162.0M |
| unusual items | -$1.3M | $370,000 | -$4.4M | -$690,000 |